Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Leigh Steinberg Appointed As Class Ii Director At Fibro Biologics
PUBLIC · FBLGAug 24, 2026•about 3 hours ago
Position
Director
Company
FibroBiologics
Leigh Steinberg
HoustonBiotechnologyHealth CareTherapeutics
Description
On August 20, 2026, FibroBiologics, Inc. appointed Leigh Steinberg as a Class II director effective immediately. He will serve until the 2028 annual meeting of stockholders
Company Information
Company
FibroBiologics
Location
455 E. Medical Center Blvd, Suite 300
Houston, Texas, United States
About
FibroBiologics is a clinical-stage biotechnology company developing a pipeline of treatments and seeking potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics holds 275+ US and internationally issued patents/patents pending across various clinical pathways, including wound healing, multiple sclerosis, disc degeneration, psoriasis, orthopedics, human longevity, and cancer. FibroBiologics represents the next generation of medical advancement in cell therapy and tissue regeneration.
Don't miss FibroBiologics's next move
Get an email the moment FibroBiologics changes its leadership, hires an exec, or expands, usually minutes after it happens.